The C.A.M. Report
Complementary and Alternative Medicine: Fair, Balanced, and to the Point
  • About this web log

    This blog is intended as an objective and dispassionate source of information on the latest CAM research. Since my background is in pharmacy and allopathic medicine, I view all CAM as advancing through the development pipeline to eventually become integrated into mainstream medical practice. Some will succeed while others fail. But all are treated fairly here.

  • About the author

    John Russo, Jr., PharmD, is president of The MedCom Resource, Inc. Previously, he was senior vice president of medical communications at www.Vicus.com, a complementary and alternative medicine website.

  • Common sense considerations

    The material on this weblog is for informational purposes. It is not medical advice or counsel. Be smart, consult your health professional before using CAM.

  • Support this site

    If you found the information here helpful, please consider supporting this site.If you found the information here helpful, please consider supporting this site.

  • Recent Posts

  • Recent Comments

    Survival with alternative therapy for breast cancer

    Some breast cancer patients reject standard treatment, but data on outcomes for those choosing CAM as primary treatment are lacking.

    Researchers at the Legacy Health System, Cancer Services, in Portland, Oregon, estimated 10-year survival statistics.

    First, the details.

    • 61 breast cancer patients who refused/delayed standard treatments in favor of alternative therapies were identified in a community surgical practice over a 10-year period.
    • Their medical records were reviewed for a duration of about 54 months, and accompanied by telephone interviews when possible.
    • Patients were stratified into 2 subgroups.
      • Those who omitted/delayed surgery
      • Patients who agreed to initial surgical therapy but were nonadherent to recommendations about hormonal therapy, chemotherapy, or radiation

    And, the results.

    • Omitted/delayed surgery
      • 96% experienced disease progression
      • 50% died of disease
      • Average stage at initial presentation was II.
        • Average stage at re-presentation after primary treatment with alternative therapies was stage IV.
    • Patients nonadherent to recommendations about hormonal therapy, chemotherapy, or radiation.
      • 86% experienced disease progression.
      • 20% died of disease.
      • Survival for this group was 36% after follow-up of about 33 months.
    • Alternative therapies
      • The most common alternative therapies used included herbal/vitamin (69%) and dietary (62%).
      • Less common: religion (4 cases), sham surgery (1), chelation/detox (5),
    • More on breast cancer staging is here.

    The bottom line?

    The authors concluded, “Alternative therapies used as primary treatment for breast cancer are associated with disease progression and increased risk of recurrence and death. Diminished outcomes are more profound in those delaying/omitting surgery.”

    Earlier detection, improved surgical options and follow-up allopathic therapy have combined to improve survival for breast cancer victims. 10-year survival reached 77% for women diagnosed with any stage breast tumor in between 1995-2004, according to a review of data at MD Anderson Cancer Center in Houston, Texas.

    Of course, what’s most important is early detection of limited (localized) disease, which then raises the 10-years estimated survival to 86%, again based on data from the University of Texas M. D. Anderson Cancer Center.

    3/14/11 19:10 JR

    Leave a Comment

    XHTML: Line-breaks are automatic. Available tags are <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>